» Articles » PMID: 33884032

Interferon-τ Regulates the Expression and Function of Bovine Leukocyte Antigen by Downregulating Bta-miR-204

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 Apr 22
PMID 33884032
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

IFN-τ is a pregnancy recognition factor that regulates embryo implantation in ruminants. IFN-τ has been suggested to be involved in the expression of microRNA (miRNA/miR) and bovine leukocyte antigen (BoLA), which is an analog of the human major histocompatibility complex class I. However, little is known about whether the miRNAs are involved in the expression of BoLA in ruminants. The present study firstly verified that bta-miR-204 was downregulated and that BoLA was upregulated in the uterine tissues of dairy cows during early pregnancy. Subsequently, luciferase reporter assays, reverse transcription-quantitative PCR and western blot analysis were used to validate BoLA as the target gene of bta-miR-204. Moreover, BoLA was markedly upregulated and bta-miR-204 was downregulated in bovine endometrial epithelial cells (bEECs) treated with IFN-τ. In addition, the results indicated that when the expression level of BoLA was increased by IFN-τ, the expression level of programmed death-ligand 1 (PD-L1) and programmed death-ligand 2 (PD-L2) was also increased. Furthermore, when BoLA was silenced in bEECs by small interfering RNA, the expression of PD-L1 and PD-L2 was not affected by IFN-τ. The expression level of PD-L1 and PD-L2 was also increased in the uterine tissues of pregnant dairy cattle. In conclusion, IFN-τ may function by suppressing the expression of bta-miR-204 to increase the expression of BoLA during the embryo implantation period in cattle. IFN-τ may induce PD-L1 and PD-L2 transcription by regulating BoLA, which may influence the T cell immune response, thereby regulating pregnant cattle immunization.

Citing Articles

Effects of conceptus proteins on endometrium and blood leukocytes of dairy cattle using transcriptome and meta-analysis.

da Silva M, Ott T bioRxiv. 2024; .

PMID: 38712302 PMC: 11071483. DOI: 10.1101/2024.04.25.591148.


Cytokines and microRNAs in SARS-CoV-2: What do we know?.

Rarani F, Rashidi B, Jafari Najaf Abadi M, Hamblin M, Hashemian S, Mirzaei H Mol Ther Nucleic Acids. 2022; 29:219-242.

PMID: 35782361 PMC: 9233348. DOI: 10.1016/j.omtn.2022.06.017.


Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons.

Ghafouri-Fard S, Poornajaf Y, Dashti F, Hussen B, Taheri M, Jamali E Front Immunol. 2022; 13:877243.

PMID: 35572537 PMC: 9091820. DOI: 10.3389/fimmu.2022.877243.


Ginsenoside Rb1 Mitigates Lipopolysaccharide-Induced Endometritis through TLR4-Mediated NF-κB Pathway.

Shaukat A, Shaukat I, Rajput S, Shukat R, Hanif S, Shaukat I Molecules. 2021; 26(23).

PMID: 34885671 PMC: 8659231. DOI: 10.3390/molecules26237089.

References
1.
Zhu Z, Li B, Wu Y, Wang X, Deng G . Interferon-τ increases BoLA-I for implantation during early pregnancy in dairy cows. Oncotarget. 2017; 8(56):95095-95107. PMC: 5707008. DOI: 10.18632/oncotarget.19282. View

2.
Ye Z, Wen D, Cai X, Liang L, Wu P, Qin H . The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics. Oncotarget. 2017; 8(62):104960-104980. PMC: 5739612. DOI: 10.18632/oncotarget.21950. View

3.
Wu H, Zhang T, Ma X, Jiang K, Zhao G, Qiu C . Specific microRNA library of IFN-τ on bovine endometrial epithelial cells. Oncotarget. 2017; 8(37):61487-61498. PMC: 5617439. DOI: 10.18632/oncotarget.18470. View

4.
Liu H, Bakthavatsalam R, Meng Z, Li Z, Li W, Perkins J . PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Transplant Proc. 2013; 45(5):1853-5. DOI: 10.1016/j.transproceed.2013.03.015. View

5.
Aust S, Felix S, Auer K, Bachmayr-Heyda A, Kenner L, Dekan S . Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer. Sci Rep. 2017; 7:42929. PMC: 5339797. DOI: 10.1038/srep42929. View